Health Condition 1: M17- Osteoarthritis of knee
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a)Age between 51-86 years b)Both sexes c)Clinically diagnosed cases of knee osteoarthritis, as per American College of Rheumatology criteria, suffering from acute painful episodes of the condition; with or without involvement of other joint(s); with or without imaging and/or other investigational evidences d)Patients already undergoing regular oral/topical analgesics/NSAIDs therapy for acute inflammatory episodes of osteoarthritis, provided the medications are stopped completely; patients on life-saving conventional drug therapies, e.g. anti-diabetics, anti-hypertensives, thyroid drugs etc. for co-morbidities under control, will be continued
Exclusion criteria
Exclusion criteria: a)Severe degeneration of knee joint with marked joint narrowing,varus, or valgus deformity of knee ( > 12�°); evidenced by imaging or other evidences and requiring surgical intervention b)Non-ambulant patients c)Self-reported joint disorders (e.g. inflammatory joint disease,specific arthropathy, severe axis deviations or instabilities, joint or skin infections, joint prostheses of the lower limbs) other than osteoarthritis d)Intra-articular injections within 2 weeks prior to study entry e)Uncontrolled, unevaluated and/or complicated diabetes mellitus, hypertension, and other co-morbidities f)Cases with other systemic unevaluated or uncontrolled diseases like cardiovascular, renal, gastro-intestinal, endocrinal, gynecological diseases etc. or systemic infections affecting quality of life or on other treatment therapies g)Psychiatric illness h)Patients with any vital organ failure i)Recent significant knee surgery within last 6 months j)Cases with transplanted knees k)History of homeopathic treatment for any chronic disease within last 6 months l)Self-reported immune-compromised states m)Alcohol/drug addiction or dependence
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 100 mm visual analogue scales for pain,stiffness, and limitation of physical functionTimepoint: 2 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| OARSI-OMERACT constant or intermittent pain measure; safety of homoeopathic treatment;need for concomitant therapy; adverse or serious adverse events; withdrawal due to adverse events or lack of efficiencyTimepoint: 2 weeks | — |
Countries
India
Contacts
Mahesh Bhattacharyya Homeopathic Medical College and Hospital